Centrexion Therapeutics
Lynne Sole is an experienced professional in the pharmaceutical industry with a background in analytical development. Lynne has held various positions in companies such as Centrexion Therapeutics Corp., Ocular Therapeutix, Inc., and X4 Pharmaceuticals, where Lynne directed analytical development activities to support drug delivery platforms and the development of new drugs for rare diseases and cancer. Lynne has a Ph.D in Organic Synthetic Chemistry and a strong educational background in chemistry and economics.